加味杜仲丸治疗肝肾亏虚型腰椎间盘突出症疗效及对疼痛程度、腰椎功能的影响
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R681.53

基金项目:

浙江省中医药科技计划项目(2023ZF116)


Efficacy of Modified Duzhong Wan in Treating Lumbar Disc Herniation of Liver-Kidney Deficiency Type and Its Effects on Pain Degree and Lumbar Function
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察加味杜仲丸治疗肝肾亏虚型腰椎间盘突出症(LDH) 的疗效及对疼痛度、腰椎功能的 影响。方法:选取2023年12月—2024年9月浙江省皮肤病医院收治的87例肝肾亏虚型LDH患者,按治疗方案 差异分成常规组42例及中药组45例。常规组口服美洛昔康胶囊,中药组服用加味杜仲丸治疗。比较2组治疗 前后中医证候积分、Oswestry残疾指数问卷(ODI) 评分、日本骨科学会(JOA) 评分、简明健康问卷(SF-36) 评分、疼痛视觉模拟评分法(VAS) 评分、神经递质及炎症相关因子[5-羟色胺(5-HT)、白细胞介 素-1β(IL-1β)、前列腺素E2(PGE2)] 水平的变化,比较2组不良反应发生率。结果:治疗后,2组腰部疼 痛、腰膝酸麻、肢体发凉、功能受限中医证候积分均较治疗前下降(P<0.05);中药组上述4项中医证候积分 均低于常规组(P<0.05)。治疗后,2组ODI评分均较治疗前下降(P<0.05),JOA评分均较治疗前上升(P< 0.05);中药组ODI评分低于常规组(P<0.05),JOA评分高于常规组(P<0.05)。治疗后,2组SF-36评分均 较治疗前上升(P<0.05),VAS 评分均较治疗前下降(P<0.05);中药组VAS 评分低于常规组(P<0.05), SF-36评分高于常规组(P<0.05)。治疗后,2组PGE2、IL-1β、5-HT水平均较治疗前下降(P<0.05),中药 组上述3项水平均低于常规组(P<0.05)。中药组不良反应发生率为6.67%(3/45),常规组为21.43%(9/42), 2组比较,差异有统计学意义(P<0.05)。结论:加味杜仲丸治疗肝肾亏虚型LDH的疗效较好,能有效减轻疼 痛程度,改善腰椎功能,提高生活质量。

    Abstract:

    Abstract: Objective: To observe the efficacy of modified Duzhong Wan in treating lumbar disc herniation (LDH) of liver-kidney deficiency type, and its effects on pain degree and lumbar function. Methods: Eighty-seven LDH patients of liver-kidney deficiency type treated at Zhejiang Provincial Dermatology Hospital from December 2023 to September 2024 were selected and divided into a conventional group (n=42,treated with Meloxicam Capsules) and a Chinese medicine group (n=45,treated with modified Duzhong Wan) according to treatment protocols. Changes in traditional Chinese medicine syndrome scores, Oswestry Disability Index (ODI) scores, Japanese Orthopaedic Association (JOA) scores,Short Form-36 Health Survey (SF-36) scores,Visual Analogue Scale (VAS) scores for pain, and levels of neurotransmitters and inflammation-related factors [5-hydroxytryptamine (5-HT), interleukin-1β( IL-1β),prostaglandin E2( PGE2)] were compared between the two groups before and after treatment, and the incidence of adverse reactions was compared. Results: After treatment, traditional Chinese medicine syndrome scores for lower back pain,soreness and numbness of waist and knees,cold limbs,and functional limitation decreased in both groups compared with those before treatment (P<0.05), and were lower in the Chinese medicine group than in the conventional group (P<0.05). After treatment, ODI scores decreased (P<0.05) and JOA scores increased (P<0.05) in both groups, with lower ODI scores (P<0.05) and higher JOA scores (P<0.05) in the Chinese medicine group. SF-36 scores increased( P<0.05) and VAS scores decreased( P<0.05) in both groups,with higher SF-36 scores (P<0.05) and lower VAS scores (P<0.05) in the Chinese medicine group. After treatment, levels of PGE2, IL-1β, and 5-HT decreased in both groups (P<0.05) and were lower in the Chinese medicine group (P<0.05). The incidence of adverse reactions was 6.67% (3/45) in the Chinese medicine group,significantly lower than that of 21.43% (9/42) in the conventional group (P<0.05). Conclusion: Modified Duzhong Wan demonstrates good efficacy in treating LDH of liver-kidney deficiency type, effectively reducing pain degree, improving lumbar function,and enhancing quality of life.

    参考文献
    相似文献
    引证文献
引用本文

周华荣,陆德忠.加味杜仲丸治疗肝肾亏虚型腰椎间盘突出症疗效及对疼痛程度、腰椎功能的影响[J].新中医,2026,58(5):62-66

复制
分享
相关视频

文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2026-03-12
  • 出版日期:
文章二维码